Staar Surgical STAA Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 76.9%+2.9pp | 76.2%-0.1pp | 73.9%-4.9pp | 71.7%-7.5pp | 74%-4.5pp | |
| Operating margin | -9.1%+15.2pp | -38.3%-34.3pp | -42%-49.5pp | -48.8%-56.7pp | -24.3%-31.3pp | |
| Net margin | -7.2%+18.2pp | -33.6%-27.2pp | -41.8%-48.2pp | -42.4%-47.4pp | -25.5%-30.2pp | |
| EBITDA margin | -6.3%+15.1pp | -34.8%-33.0pp | -38.2%-47.5pp | -45.1%-54.6pp | -21.4%-30.1pp | |
| Free cash flow margin | -19.6%-8.3pp | -17.5%-15.0pp | -17.9%— | -19.5%— | -11.2%— | |
| Returns | ||||||
| Return on equity | -6%+13.2pp | -21.7%-16.5pp | -24.6%-30.0pp | -25.6%-29.9pp | -19.1%-23.3pp | |
| Return on assets | -4.6%+10.3pp | -16.7%-12.7pp | -19.4%-23.7pp | -20%-23.5pp | -15%-18.3pp | |
| Return on invested capital | -11.2%+21.2pp | -35.2%-30.4pp | -37.2%-42.6pp | -47.4%-53.0pp | -32.4%-37.8pp | |
| Efficiency | ||||||
| Asset turnover | 0.6×+0.1× | 0.5×-0.1× | 0.5×-0.2× | 0.5×-0.2× | 0.6×-0.1× | |
| Liquidity | ||||||
| Current ratio | 5.1×+0.3× | 4.5×-0.7× | 5.2×-0.8× | 4.9×-0.9× | 4.8×-1.1× | |
| Quick ratio | 5.2×+0.5× | 4.5×-0.7× | 5.2×-0.8× | 4.9×-0.9× | 4.7×-1.1× | |
| Cash ratio | 2.2×-0.4× | 2.2×+0.2× | 2.9×+0.4× | 2.8×-0.1× | 2.5×-1.0× | |
| Leverage | ||||||
| Debt-to-equity | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | |
| Debt-to-assets | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | |
| Interest coverage | -6.4×+5.4× | -20×-17.8× | -19.1×-23.3× | -19.3×-23.4× | -11.8×-15.2× | |
| Per Share | ||||||
| Book value per share | $6.92-2.4% | $6.94-14.2% | $7.00-18.7% | $6.80-17.2% | $7.09-11.7% | |
| Valuation | ||||||
| Market capitalization | $1.44B+77.9% | $935.48M-21.5% | $1.28B-10.5% | $887.26M-56.0% | $885.53M-60.6% | |
| Enterprise value | $1.35B+100.0% | $820.69M-24.5% | $1.14B-12.5% | $760.65M-59.1% | $749.09M-63.6% | |
| Price / sales | 5×+2.1× | 3.9×+0.1× | 5.5×+1.4× | 4×-2.1× | 3.2×-3.7× | |
| Price / book | 4.1×+1.8× | 2.7×-0.3× | 3.6×+0.3× | 2.6×-2.3× | 2.5×-3.2× | |
| EV / sales | 4.6×+2.2× | 3.4×0.0× | 4.9×+1.1× | 3.4×-2.2× | 2.7×-3.6× | |
| Free cash flow yield | -3.9%-0.1pp | -4.5%-3.8pp | -3.2%— | -4.9%— | -3.5%— | |
| Earnings yield | -1.5%+7.3pp | -8.6%-6.9pp | -7.5%-9.1pp | -10.7%-11.6pp | -8%-8.7pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Staar Surgical's profit margins?
- Staar Surgical (STAA) runs a 76.9% gross margin and a -9.1% operating margin, with a -7.2% net margin.
- Where do Staar Surgical's ratios come from?
- Every ratio is computed from Staar Surgical's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
